Fujifilm Diosynth
Fujifilm Diosynth

Fujifilm’s Bold Move: Dominating Drug Development!
BIOT
Fujifilm rebrands life sciences, unifying strategies to lead in drug development and biomanufacturing. 🌟🔍💼🚀 LifeSciences Fujifilm

Regeneron and FUJIFILM Ink $3B Manufacturing Deal!
BIOT
Exciting news! 🎉 FUJIFILM Diosynth and Regeneron sign a 10-year, $3+ billion deal to boost U.S. biologic medicine production! 🏭💼

Fujifilm Diosynth Invests $12B in Massive NC Expansion
BIOT
📢 Fujifilm Diosynth Biotechnologies invests $1.2B to expand biomanufacturing facility in NC, creating 680 new jobs. 🏭💼🌍📈





